Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices.
But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Henry Schein currently trades at $64.88 per share and has shown little upside over the past six months, posting a middling return of 3.5%. The stock also fell short of the S&P 500’s 34.7% gain during that period.
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index.
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
Shares of dental and medical products company Henry Schein (NASDAQ:HSIC)
fell 2.7% in the afternoon session after the U.S. Commerce Department initiated a national security investigation into medical equipment and devices, raising concerns about potential tariffs.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at dental equipment & technology stocks, starting with Henry Schein (NASDAQ:HSIC).
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner.
Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.
Dental and medical products company Henry Schein (NASDAQ:HSIC) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.3% year on year to $3.24 billion. Its non-GAAP profit of $1.10 per share was 7.6% below analysts’ consensus estimates.
Shares of dental and medical products company Henry Schein (NASDAQ:HSIC)
fell 9.7% in the afternoon session after the company reported second-quarter earnings that missed profit expectations and showed a year-over-year decline.
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session.
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index.
Henry Schein Inc. stock down on Q2 earnings, misses EPS but beats sales. Total net sales up 3.3%, $23M in restructuring costs. FY2025 guidance affirmed.
Dental and medical products company Henry Schein (NASDAQ:HSIC) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.3% year on year to $3.24 billion. Its non-GAAP profit of $1.10 per share was 7.6% below analysts’ consensus estimates.
